This protein is released by activated neutrophils; S100A9 levels were elevated in samples from patients suffering from neutrophilic asthma than in the ones from healthy individuals, thus presenting a potential for this protein as a biomarker for asthma. This evidence concerns the gene S100A9 and asthma.